Treatment for skin redness associated with rosacea, actinic solar purpura and peri-procedural bruising of the skin. (Acquired by Allergan)
Location: United States, Pennsylvania, Malvern
Total raised: $16M
Investors 2
| Date | Name | Website |
| - | Sofinnova ... | sofinnova.... |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.06.2010 | Series A | $16M | - |
Mentions in press and media 3
| Date | Title | Description |
| 30.06.2010 | Vicept Therapeutics completes $16M Series A round | The funding round was led by California-based Vivo Ventures, California-based Sofinnova Ventures and Massachusetts-based Fidelity Biosciences, according to a statement from Vicept. Vicept also plans to use the money to investigate other dru... |
| 30.06.2010 | Vicept Therapeutics Raises $10M to Complete Series A Financing | Vicept Therapeutics Inc., a Malvern, Pennsylvania-based specialty biopharmaceutical company dedicated to developing a topically applied therapy for erythema (facial redness) of rosacea, a common, chronic condition of the skin, has secured $... |
| - | Vicept Therapeutics completes $16M Series A round | Vicept Therapeutics Inc., a developer of topical treatments for skin disorders, has completed a $16 million Series A round of funding. The Malvern, Penn. company plans to use the cash to fund Phase 1 and 2 development of V-101, the company’... |